Deferred Tax Assets, Valuation Allowance in USD of Lipocine Inc. from Q4 2011 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Lipocine Inc. quarterly Deferred Tax Assets, Valuation Allowance history and change rate from Q4 2011 to Q4 2024.
  • Lipocine Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $48,222,797, a 0.98% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Lipocine Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $48,222,797 +$467,135 +0.98% 31 Dec 2024 10-K 13 Mar 2025 2024 FY
Q4 2023 $47,755,662 +$1,896,158 +4.1% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q4 2022 $45,859,504 +$2,841,169 +6.6% 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q4 2021 $43,018,335 +$563,243 +1.3% 31 Dec 2021 10-K 10 Mar 2023 2022 FY
Q4 2020 $42,455,092 +$5,190,653 +14% 31 Dec 2020 10-K 09 Mar 2022 2021 FY
Q4 2019 $37,264,439 +$3,770,759 +11% 31 Dec 2019 10-K 11 Mar 2021 2020 FY
Q4 2018 $33,493,680 +$2,680,410 +8.7% 31 Dec 2018 10-K 13 Mar 2020 2019 FY
Q4 2017 $30,813,270 -$5,091,657 -14% 31 Dec 2017 10-K 06 Mar 2019 2018 FY
Q4 2016 $35,904,927 +$7,704,070 +27% 31 Dec 2016 10-K 12 Mar 2018 2017 FY
Q4 2015 $28,200,857 +$7,314,046 +35% 31 Dec 2015 10-K 06 Mar 2017 2016 FY
Q4 2014 $20,886,811 +$9,226,564 +79% 31 Dec 2014 10-K 10 Mar 2016 2015 FY
Q4 2013 $11,660,247 +$40,669 +0.35% 31 Dec 2013 10-K 11 Mar 2015 2014 FY
Q2 2013 $13,220* 30 Jun 2013 10-Q 09 Jul 2013 2013 Q2
Q1 2013 $12,754* 31 Mar 2013 10-Q 24 Apr 2013 2013 Q1
Q4 2012 $11,619,578 +$11,620,352 31 Dec 2012 10-K 31 Mar 2014 2013 FY
Q4 2011 $774* 31 Dec 2011 10-K 26 Feb 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.